s.bergstrom
TL2 Moderator · Split
Contributes reviews on supplier material. Based in Split.
Joined 7 March 2025 · last posted 5d · groups: regional-apac
62 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions — does this still hold? Replied, post #30 · Access › Shortages · 23 Jul 2026 · 3 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Irish differences from the UK position — what changed since Replied, post #8 · Regional › UK & Ireland · 22 Jul 2026 · 3 likes post #7 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Priming a pen and whether the primed volume is wasted Replied, post #13 · Devices › Pens & autoinjectors · 19 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #52 · Start Here › Welcome · 17 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #4 · Compounds › Repair & healing peptides · 10 Jul 2026 · 0 likes post #3 answers the question as asked. The question underneath it is different. What would change the position on repair peptides: adequately powered, published,…
-
Immortal time bias in a claims-database study — one year on Replied, post #11 · Evidence › Study critique · 7 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #26 · Analytics › Home & field testing · 25 Jun 2026 · 0 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #60 · Access › Insurance & coverage · 6 Jun 2026 · 28 likes I read post #58 twice before replying, because I had assumed the opposite. Reimbursement changes: a compound covered one year might not be the next. A formulary…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #88 · Sourcing › Red flags · 6 Jun 2026 · 0 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #30 · Clinical › Special populations · 29 May 2026 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical…
-
Follow-up: Sleep quality changes during weight loss Replied, post #31 · Wellbeing › Sleep · 27 May 2026 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Started this topic · Compounds › Cagrilintide & amylin analogues · 24 May 2026 · 40 likes Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #7 · Sourcing › Independent verification · 26 Apr 2026 · 3 likes post #6 answers the question as asked. The question underneath it is different. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #83 · Compounds › Tirzepatide · 15 Apr 2026 · 20 likes Worth separating two things that post #79 runs together. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #35 · Sourcing › Logistics · 6 Apr 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Blinding yourself: practical methods and their limits Replied, post #14 · Research Methods › N-of-1 designs · 29 Mar 2026 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #5 · Practice › Reconstitution · 28 Mar 2026 · 6 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #18 · Sourcing › Red flags · 18 Mar 2026 · 17 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Preprint servers and what screening they do Replied, post #86 · Evidence › Preprints · 12 Mar 2026 · 6 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #74 · Compounds › Semaglutide · 4 Mar 2026 · 0 likes Coming back to post #72, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #79 · Practice › Dosing & titration · 19 Feb 2026 · 2 likes This follows post #76 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #74 · Clinical › Bloodwork · 12 Feb 2026 · 27 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Amylin receptor signalling and satiety — what changed since Replied, post #23 · Pharmacology › Receptor biology · 30 Jan 2026 · 30 likes This follows post #20 rather than contradicting it. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
-
Request: export my own posts — one year on Replied, post #40 · Meta › Feature requests · 29 Jan 2026 · 3 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
Designing a personal experiment that could change your mind — one year on Replied, post #6 · Research Methods › N-of-1 designs · 29 Jan 2026 · 28 likes Picking up post #3: that is the part I would want checked first. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For…
-
MHRA statements, read directly Replied, post #74 · Regional › UK & Ireland · 23 Jan 2026 · 3 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Personal import allowances, compared — a second dataset Replied, post #54 · Access › International · 19 Jan 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
What a purity-only report leaves out Replied, post #104 · Sourcing › Independent verification · 26 Nov 2025 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #52 · Practice › Interactions · 18 Nov 2025 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #5 · Safety › Contraindications · 14 Nov 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #29 · Start Here › How to Ask · 26 Oct 2025 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Amylin receptor signalling and satiety Replied, post #11 · Pharmacology › Receptor biology · 25 Oct 2025 · 6 likes post #10 is right about the mechanism and I think understates the practical bit. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #112 · Analytics › HPLC & UHPLC · 18 Oct 2025 · 7 likes Coming back to post #110, because the follow-up matters more than the original answer. Before anything else: what was the gradient, and at what wavelength? Area percent…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #23 · Devices › Pens & autoinjectors · 14 Oct 2025 · 17 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
Documentation that materially improves an appeal's chances Replied, post #20 · Access › Insurance & coverage · 6 Oct 2025 · 8 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #57 · Practice › Reconstitution · 18 Sep 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #121 · Access › Insurance & coverage · 15 Sep 2025 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #58 · Compounds › Semaglutide · 14 Sep 2025 · 15 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #29 · Compounds › Oral incretins · 29 Aug 2025 · 32 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Repeatability versus intermediate precision Replied, post #34 · Analytics › Method validation · 21 Jun 2025 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Regional warehouse stock versus direct despatch Replied, post #2 · Sourcing › Logistics · 29 May 2025 · 10 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 21 May 2025 · 6 likes post #44 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Vagal afferents and the gut-brain pathway Replied, post #4 · Pharmacology › Receptor biology · 15 May 2025 · 5 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
A claim built entirely on a subgroup analysis Replied, post #22 · Evidence › Study critique · 7 May 2025 · 7 likes post #21 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #20 · Practice › Dosing & titration · 5 May 2025 · 17 likes This follows post #17 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #96 · Compounds › Cagrilintide & amylin analogues · 11 Apr 2025 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #30 · Sourcing › Vendor reports · 28 Mar 2025 · 9 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #38 · Access › Pricing · 19 Mar 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Maintainer handover: how it works Replied, post #72 · Meta › Wiki maintenance · 18 Mar 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #44 · Practice › Reconstitution · 1 Mar 2025 · 18 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Ipamorelin selectivity claims and where they came from Replied, post #14 · Compounds › Secretagogues & GH axis · 18 Feb 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #22 · Data & Tools › Calculators · 31 Jan 2025 · 3 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Reading an MS report that only gives you a single number Replied, post #2 · Analytics › Mass spectrometry · 27 Jan 2025 · 11 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Distinguishing a deletion sequence by mass alone Replied, post #9 · Analytics › Mass spectrometry · 22 Jan 2025 · 5 likes Resolution: "high resolution" commonly means
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #89 · Compounds › Semaglutide · 21 Jan 2025 · 30 likes post #88 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
-
Follow-up: Individual participant data versus aggregate data Replied, post #81 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Why "any advice?" is the least effective ending for a post Replied, post #34 · Start Here › How to Ask · 14 Nov 2024 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Second pass at: Reimbursement variation across member states Replied, post #5 · Regional › European Union · 31 Aug 2024 · 0 likes Picking up post #2: that is the part I would want checked first. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #11 · Practice › Administration · 7 Aug 2024 · 24 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Guidelines revision: what changed and why Replied, post #30 · Meta › Announcements · 25 Jul 2024 · 26 likes post #29 is right about the mechanism and I think understates the practical bit. Staff-only posts: some announcements are visible only to staff (concerning internal…
-
Blind submission and why it changes minds Replied, post #15 · Sourcing › Independent verification · 15 Jul 2024 · 0 likes This follows post #12 rather than contradicting it. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #74 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.